- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03808246
Detection of Usability Errors of a Medical Device Zeneo®
연구 개요
상세 설명
In order to determine how many participants must be recruited to detect 95% of the anticipated use errors, two groups of participants (naives or informed to the type of device under evaluation) will take part to usability test of a demo version of an auto injector pen in one of two test environments (realistic or laboratory-like). The combination of the 2 types of users and the two types of environment composes 4 arms.
By default, 15 participants will be recruited per arm (in conformity with usual guidelines). If, in a given group, 95% of anticipated errors are detected, no more participants will be recruited in the arm. Otherwise, 5 other participants will be recruited till the 95% threshold is reached with a maximum of 40 participants per group.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Haut De France
-
Lille, Haut De France, 프랑스, 59037
- Usability Lab of CIC IT 1403
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Two types of participants (healthy people) will be recruited: participants informed about auto-injector pens (BUT NOT PATIENTS) and participants naïves on this topic.
Inclusion Criteria:
- Able to use the device
- Without previous experience of anaphylactic shock
- Not taking a psychotropic drug
- Without hearing impairment
- Covered by social security
- Who signed the consent form and the information letter
- Who agree to conform to the procedure of the study -
Exclusion Criteria:
- Pregnant women
- Vulnerable Persons
- Persons under administrative supervision
- Persons who are subject to a judicial protection measure
- Persons who do not understand correctly French.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: naive/realistic environment
This arm includes included participants who are naive in terms of self-injector pens and who have been randomly attributed to the "realistic environment" condition of simulation. The intervention is "using the demo version of a self-injector pen". |
Participants, whatever the arm they are included in, will have to use the demo version of the auto-injector pen during a simulation of an anaphylactic shock.
|
실험적: informed/realistic environment
This arm includes included participants who are informed in terms of self-injector pens and who have been randomly attributed to the "realistic environment" condition of simulation. The intervention is "using the demo version of a self-injector pen". |
Participants, whatever the arm they are included in, will have to use the demo version of the auto-injector pen during a simulation of an anaphylactic shock.
|
실험적: informed/laboratory-like environment
This arm includes included participants who are informed in terms of self-injector pens and who have been randomly attributed to the "laboratory-like environment" condition of simulation. The intervention is "using the demo version of a self-injector pen". |
Participants, whatever the arm they are included in, will have to use the demo version of the auto-injector pen during a simulation of an anaphylactic shock.
|
실험적: naive/laboratory-like environment
This arm includes included participants who are naive in terms of self-injector pens and who have been randomly attributed to the "laboratory-like environment" condition of simulation. The intervention is "using the demo version of a self-injector pen". |
Participants, whatever the arm they are included in, will have to use the demo version of the auto-injector pen during a simulation of an anaphylactic shock.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
For each arm, number of participants needed to uncover 95% of the use errors known
기간: through study completion, an average of 6 months
|
through study completion, an average of 6 months
|
2차 결과 측정
결과 측정 |
기간 |
---|---|
number of use errors uncovered per participant
기간: through study completion, an average of 6 months
|
through study completion, an average of 6 months
|
number of participants who detected a given error
기간: through study completion, an average of 6 months
|
through study completion, an average of 6 months
|
number of unanticipated errors detected
기간: through study completion, an average of 6 months
|
through study completion, an average of 6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Romaric Marcilly, PhD, University Hospital, Lille
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2017_16
- 2017-A02847-46 (기타 식별자: ID-RCB number, ANSM)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .